Semaglutide: Research Overview
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has been extensively studied in metabolic and endocrine research. It mimics the incretin hormone GLP-1, which plays crucial roles in glucose metabolism and appetite regulation.
Peptide Profile
| Property | Details |
|---|---|
| Class | GLP-1 Receptor Agonist |
| Type | Modified peptide |
| Amino Acids | 31 |
| Modifications | Acylation, amino acid substitutions |
| Purity | 99%+ (HPLC verified) |
| Form | Lyophilized powder |
GLP-1 and Its Role
Natural GLP-1
Glucagon-like peptide-1 is an incretin hormone produced in the intestines in response to food intake. It:
The Challenge
Natural GLP-1 has a very short half-life (1-2 minutes) due to rapid degradation by the enzyme DPP-4 (dipeptidyl peptidase-4). This makes it impractical for research requiring sustained activity.
Semaglutide: Structural Modifications
Semaglutide incorporates several modifications to enhance stability:
1. Amino Acid Substitutions
- Provides DPP-4 resistance
2. Fatty Acid Attachment
- Enables albumin binding
- Dramatically extends half-life
- Provides sustained activity
3. Result
These modifications extend the research-relevant half-life significantly compared to native GLP-1, making it practical for various research applications.
Research Applications
Metabolic Research
Receptor Studies
Comparative Research
Cell Biology
Mechanism of Action
Semaglutide binds to and activates the GLP-1 receptor, which:
Related Compounds
Semaglutide belongs to a class of GLP-1 receptor agonists:
| Compound | Key Feature |
|---|---|
| Semaglutide | C-18 fatty acid, extended action |
| Liraglutide | C-16 fatty acid |
| Tirzepatide | Dual GIP/GLP-1 agonist |
| Retatrutide | Triple agonist (GIP/GLP-1/Glucagon) |
| Native GLP-1 | Short half-life, reference compound |
Reconstitution Guidelines
Important Considerations
Due to its fatty acid modification, semaglutide may require slightly different handling:
Standard Protocol
| Vial Size | BAC Water | Concentration |
|---|---|---|
| 3mg | 1.5ml | 2,000mcg/ml |
| 5mg | 2.5ml | 2,000mcg/ml |
Procedure
Storage Requirements
Lyophilized
Reconstituted
Research Considerations
Dosing in Research
Research concentrations vary widely based on:
Controls
When researching semaglutide, consider including:
Quality Indicators
Acceptable Appearance
Lyophilized:
Reconstituted:
Signs of Degradation
Conclusion
Semaglutide represents a significant advancement in GLP-1 receptor research tools. Its enhanced stability allows for research applications not possible with native GLP-1. As with all research peptides, semaglutide is intended for laboratory research purposes only.
*Note: Semaglutide is sold for research purposes only. Pharmaceutical semaglutide products for human use are available only by prescription.*
Frequently Asked Questions
What makes semaglutide different from natural GLP-1?
Semaglutide has structural modifications including amino acid substitutions and a C-18 fatty acid chain that dramatically extend its stability and half-life compared to native GLP-1, which degrades within minutes.
What research areas use semaglutide?
Semaglutide is used in metabolic research, glucose homeostasis studies, GLP-1 receptor binding studies, pancreatic beta cell research, and comparative studies with other GLP-1 agonists.
How should research semaglutide be stored?
Lyophilized semaglutide should be stored at -20°C protected from light for long-term storage. Once reconstituted, refrigerate at 2-8°C, protect from light, and use within 4-6 weeks.
Need Help with Dosing?
Use our calculator to determine exact amounts for your research.
Peptide Calculator